{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:15:48Z","timestamp":1759335348044},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1097\/md.0000000000010696","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T02:38:23Z","timestamp":1525833503000},"page":"e0696","source":"Crossref","is-referenced-by-count":23,"title":["Coexistence of Lambert\u2013Eaton myasthenic syndrome and autoimmune encephalitis with anti-CRMP5\/CV2 and anti-GABAB receptor antibodies in small cell lung cancer"],"prefix":"10.1097","volume":"97","author":[{"given":"Hongfang","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aimei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanlei","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongzhi","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhanyun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-40-20210309","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1212\/WNL.0b013e318224afde","article-title":"Encephalitis and antibodies to synaptic and neuronal cell surface proteins","volume":"77","author":"Lancaster","year":"2011","journal-title":"Neurology"},{"key":"R2-40-20210309","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/00207454.2016.1176922","article-title":"Clinical, imaging, and follow-up observations of patients with anti-GABAB receptor encephalitis","volume":"127","author":"Qiao","year":"2017","journal-title":"Int J Neurosci"},{"key":"R3-40-20210309","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/01616412.2017.1351062","article-title":"Encephalitis with antibodies against the GABAB receptor: seizures as the most common presentation at admission","volume":"39","author":"Chen","year":"2017","journal-title":"Neurol Res"},{"key":"R4-40-20210309","first-page":"7","article-title":"The gamma-aminobutyric acid-B receptor (GABAB) encephalitis: clinical manifestations and response to immunotherapy.","volume":"1-","author":"Cui","year":"2017","journal-title":"Int J Neurosci"},{"key":"R5-40-20210309","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s00415-009-5431-9","article-title":"Antibodies and neuronal autoimmune disorders of the CNS","volume":"257","author":"Graus","year":"2010","journal-title":"J Neurol"},{"key":"R6-40-20210309","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1212\/WNL.0000000000001721","article-title":"Paraneoplastic neurologic disorders in small cell lung carcinoma: a prospective study","volume":"85","author":"Gozzard","year":"2015","journal-title":"Neurology"},{"key":"R7-40-20210309","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1212\/WNL.0b013e3182a9585f","article-title":"Encephalitis and GABAB receptor antibodies: novel findings in a new case series of 20 patients","volume":"81","author":"H\u00f6ftberger","year":"2013","journal-title":"Neurology"},{"key":"R8-40-20210309","doi-asserted-by":"crossref","first-page":"37957","DOI":"10.1074\/jbc.M003277200","article-title":"Molecular characterization of CRMP5, a novel member of the collapsin response mediator protein family","volume":"275","author":"Fukada","year":"2000","journal-title":"J Biol Chem"},{"key":"R9-40-20210309","doi-asserted-by":"crossref","first-page":"e103","DOI":"10.1212\/WNL.0000000000004803","article-title":"Autoimmune CRMP5 neuropathy phenotype and outcome defined from 105 cases","volume":"90","author":"Dubey","year":"2018","journal-title":"Neurology"},{"key":"R10-40-20210309","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/ana.25131","article-title":"Autoimmune encephalitis epidemiology and a comparison to infectious encephalitis","volume":"83","author":"Dubey","year":"2018","journal-title":"Ann Neurol"},{"key":"R11-40-20210309","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1474-4422(15)00401-9","article-title":"A clinical approach to diagnosis of autoimmune encephalitis","volume":"15","author":"Graus","year":"2016","journal-title":"Lancet Neurol"},{"key":"R12-40-20210309","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jneuroim.2014.05.011","article-title":"Conjoint occurrence of GABAB receptor antibodies in Lambert-Eaton myasthenic syndrome with antibodies to the voltage gated calcium channel","volume":"273","author":"Dogan Onugoren","year":"2014","journal-title":"J Neuroimmunol"},{"key":"R13-40-20210309","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/CND.0000000000000192","article-title":"Paraneoplastic Lambert-Eaton Myasthenic syndrome with limbic encephalitis: clinical correlation with the coexistence of anti-VGCC and anti-GABAB receptor antibodies","volume":"19","author":"Cho","year":"2017","journal-title":"J Clin Neuromuscul Dis"},{"key":"R14-40-20210309","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cne.24368","article-title":"GABAA and GABAB receptor subunit localization on neurochemically identified neurons of the human subthalamic nucleus","volume":"526","author":"Wu","year":"2018","journal-title":"J Comp Neurol"},{"key":"R16-40-20210309","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1097\/RLU.0000000000000676","article-title":"(18)F-FDG PET\/CT and MRI findings in a patient with anti-GABA(B) receptor encephalitis","volume":"40","author":"Su","year":"2015","journal-title":"Clin Nucl Med"},{"key":"R17-40-20210309","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1136\/jnnp.2008.149336","article-title":"CRMP5 antibodies found in a patient with limbic encephalitis and myasthenia gravis","volume":"80","author":"Monstad","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R18-40-20210309","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1097\/PAS.0b013e31817dc37c","article-title":"Extensive expression of collapsin response mediator protein 5 (CRMP5) is a specific marker of high-grade lung neuroendocrine carcinoma","volume":"32","author":"Meyronet","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R19-40-20210309","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1111\/resp.12292","article-title":"Paraneoplastic Hu and CRMP5 antibodies are present in smokers without cancer or neurological disease","volume":"19","author":"Qvale","year":"2014","journal-title":"Respirology"},{"key":"R20-40-20210309","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/jnnp.2007.138016","article-title":"Onco-neural antibodies and tumour type determine survival and neurological symptoms in paraneoplastic neurological syndromes with Hu or CV2\/CRMP5 antibodies","volume":"80","author":"Honnorat","year":"2009","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000010696","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T03:08:04Z","timestamp":1620961684000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00005792-201805110-00040"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":19,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000010696","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]}}}